JP2024524552A5 - - Google Patents
Info
- Publication number
- JP2024524552A5 JP2024524552A5 JP2024500258A JP2024500258A JP2024524552A5 JP 2024524552 A5 JP2024524552 A5 JP 2024524552A5 JP 2024500258 A JP2024500258 A JP 2024500258A JP 2024500258 A JP2024500258 A JP 2024500258A JP 2024524552 A5 JP2024524552 A5 JP 2024524552A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2109894.2 | 2021-07-08 | ||
| GBGB2109894.2A GB202109894D0 (en) | 2021-07-08 | 2021-07-08 | Novel treatments |
| GB2112976.2 | 2021-09-10 | ||
| GBGB2112976.2A GB202112976D0 (en) | 2021-09-10 | 2021-09-10 | Novel treatments |
| PCT/EP2022/068974 WO2023281007A1 (en) | 2021-07-08 | 2022-07-07 | Melflufen for use in the treatment of multiple myeloma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024524552A JP2024524552A (ja) | 2024-07-05 |
| JPWO2023281007A5 JPWO2023281007A5 (https=) | 2025-07-10 |
| JP2024524552A5 true JP2024524552A5 (https=) | 2025-07-10 |
Family
ID=82702963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500258A Pending JP2024524552A (ja) | 2021-07-08 | 2022-07-07 | 多発性骨髄腫の治療に使用するためのメルフルフェン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240307480A1 (https=) |
| EP (1) | EP4366721A1 (https=) |
| JP (1) | JP2024524552A (https=) |
| TW (1) | TW202317084A (https=) |
| WO (1) | WO2023281007A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024121349A1 (en) * | 2022-12-08 | 2024-06-13 | Oncopeptides Ab | Therapeutic treatment for haematological cancer based on the level of t-cell function |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0002202D0 (sv) | 2000-06-13 | 2000-06-13 | Karolinska Innovations Ab | New peptides |
| CA3024230C (en) | 2011-04-28 | 2022-10-18 | Oncopeptides Ab | Lyophilized preparation of cytotoxic dipeptides |
| WO2014065751A1 (en) | 2012-10-26 | 2014-05-01 | Oncopeptides Ab | Lyophilized preparations of melphalan flufenamide |
| GB201521217D0 (en) * | 2015-12-01 | 2016-01-13 | Oncopeptides Ab | Dosage regimens |
| PL3866931T3 (pl) | 2018-10-18 | 2023-06-19 | Oncopeptides Ab | Związki zawierające deuter |
| GB201905477D0 (en) | 2019-04-17 | 2019-05-29 | Oncopeptides Ab | Novel formulations |
-
2022
- 2022-07-07 WO PCT/EP2022/068974 patent/WO2023281007A1/en not_active Ceased
- 2022-07-07 US US18/576,878 patent/US20240307480A1/en active Pending
- 2022-07-07 EP EP22747660.3A patent/EP4366721A1/en active Pending
- 2022-07-07 JP JP2024500258A patent/JP2024524552A/ja active Pending
- 2022-07-08 TW TW111125748A patent/TW202317084A/zh unknown